Application 091544
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LITHIUM CARBONATE | LITHIUM CARBONATE | TABLET, EXTENDED RELEASE;ORAL | 300MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50090-1470 | Lithium Carbonate | Lithium Carbonate | A-S Medication Solutions | ANDA | Current |
| 50090-1470 | Lithium Carbonate | Lithium Carbonate | A-S Medication Solutions | ANDA | Current |
| 50090-1470 | Lithium Carbonate | Lithium Carbonate | A-S Medication Solutions | ANDA | Current |
| 50090-1470 | Lithium Carbonate | Lithium Carbonate | A-S Medication Solutions | ANDA | Current |
| 68462-223 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-223 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-223 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-223 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |